Myocardial ischemic disease is the major cause of death worldwide. After myocardial infarction, reperfusion of infracted heart has been an important objective of strategies to improve outcomes. However, cardiac ischemia/reperfusion (I/R) is characterized by inflammation, arrhythmias, cardiomyocyte damage, and, at the cellular level, disturbance in Ca 2+ and redox homeostasis. In this study, we sought to determine how acute inflammatory response contributes to reperfusion injury and Ca 2+ homeostasis disturbance after acute ischemia. Using a rat model of I/R, we show that circulating levels of TNF-α and cardiac caspase-8 activity were increased within 6 h of reperfusion, leading to myocardial nitric oxide and mitochondrial ROS production. At 1 and 15 d after reperfusion, caspase-8 activation resulted in S-nitrosylation of the RyR2 and depletion of calstabin2 from the RyR2 complex, resulting in diastolic sarcoplasmic reticulum (SR) Ca 2+ leak. Pharmacological inhibition of caspase-8 before reperfusion with Q-LETD-OPh or prevention of calstabin2 depletion from the RyR2 complex with the Ca 2+ channel stabilizer S107 ("rycal") inhibited the SR Ca 2+ leak, reduced ventricular arrhythmias, infarct size, and left ventricular remodeling after 15 d of reperfusion. TNF-α-induced caspase-8 activation leads to leaky RyR2 channels that contribute to myocardial remodeling after I/R. Thus, early prevention of SR Ca 2+ leak trough normalization of RyR2 function is cardioprotective.
Myocardial ischemic disease is the major cause of death worldwide. After myocardial infarction, reperfusion of infracted heart has been an important objective of strategies to improve outcomes. However, cardiac ischemia/reperfusion (I/R) is characterized by inflammation, arrhythmias, cardiomyocyte damage, and, at the cellular level, disturbance in Ca 2+ and redox homeostasis. In this study, we sought to determine how acute inflammatory response contributes to reperfusion injury and Ca 2+ homeostasis disturbance after acute ischemia. Using a rat model of I/R, we show that circulating levels of TNF-α and cardiac caspase-8 activity were increased within 6 h of reperfusion, leading to myocardial nitric oxide and mitochondrial ROS production. At 1 and 15 d after reperfusion, caspase-8 activation resulted in S-nitrosylation of the RyR2 and depletion of calstabin2 from the RyR2 complex, resulting in diastolic sarcoplasmic reticulum (SR) Ca 2+ leak. Pharmacological inhibition of caspase-8 before reperfusion with Q-LETD-OPh or prevention of calstabin2 depletion from the RyR2 complex with the Ca 2+ channel stabilizer S107 ("rycal") inhibited the SR Ca 2+ leak, reduced ventricular arrhythmias, infarct size, and left ventricular remodeling after 15 d of reperfusion. TNF-α-induced caspase-8 activation leads to leaky RyR2 channels that contribute to myocardial remodeling after I/R. Thus, early prevention of SR Ca 2+ leak trough normalization of RyR2 function is cardioprotective.
M yocardial infarction is, in the United States with >1.5 million new cases diagnosed each year, a leading cause of death. Reperfusion of infracted heart has been the main strategy to improve outcomes (1) . However, cardiac ischemia/reperfusion (I/R) is characterized by arrhythmias, cardiomyocyte damage, inflammation, and, at the cellular level, disturbance in Ca 2+ and redox homeostasis.
Elevated plasma levels of tumor necrosis factor α (TNF-α) have been reported in cardiac reperfusion injury, myocardial infarction, and in congestive heart failure. TNF-α induces pleiotropic effects that are mediated through activation of two distinct receptors: TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2) (2) . Most of the deleterious effects are mediated by TNFR1 signaling (3) . TNF-α also has long-term beneficial effects due to the induction of cytoprotective genes involved in cellular growth, survival, and proliferation (4) . Thus, release of TNF-α after myocardial injury may activate signaling pathways that promote either cardiac adaptation/protection or maladaptive responses. Multicenter trials using TNF-α antagonists in moderate to severe heart failure (HF) demonstrated adverse effects instead of benefits (5, 6) . Therefore, a new therapeutic strategy specifically targeting early deleterious effects of TNF-α, without affecting its cytoprotective activity, remains of interest.
One of the early events in the TNF-α/TNFR1 signaling pathways is activation of caspase-8 (7). This pathway is initiated by recruitment of the adaptor protein Fas-associated via a death domain (FADD), which then recruits procaspase-8 into the death-inducing signaling complex (DISC). Caspase-8 activation leads to the generation of ceramide, mitochondrial reactive oxygen species (ROS) production, Bid cleavage, followed by cytochrome c release from mitochondria, and apoptosome formation, ultimately leading to activation of effectors caspases (i.e., caspase-3) and cell death (8) (9) (10) . In parallel, acute nitric oxide (NO) production through activation of the endothelial nitric oxide synthase (eNOS), or increased expression of inducible nitric oxide synthase (iNOS) inhibit key apoptogenic signals triggered by TNF-α such as ceramide formation and caspase-8 (11, 12) .
Increased ROS and/or NO-derived reactive species (RNS) change the redox environment of Ca 2+ transporters and channels and, thus, affect cellular Ca 2+ cycling (13) . The cardiac ryanodine receptor (RyR2) that mediates sarcoplasmic reticulum (SR) Ca 2+ release during excitation-contraction coupling contains ≈33 free thiol residues, rendering it highly sensitive to the cellular redox state. Cysteine oxidation facilitates RyR opening and SR Ca 2+ leak (14, 15) . Moreover, we have recently shown that S-nitrosylation of RyR1 (skeletal muscle) and RyR2 (cardiac muscle) and dissociation of their stabilizing subunit calstabin1 (FKBP12) or calstabin2 (FKBP12.6), respectively, induces SR Ca 2+ leak, cardiac arrhythmia, skeletal muscle weakness, and remodeling in a Duchene muscular dystrophy (mdx) mouse model (16, 17) .
In this study, we sought to determine whether TNF-α-induced caspase-8 activation would affect RyR2 S-nitrosylation leading to diastolic SR Ca 2+ leak and left ventricular remodeling in a rat model of I/R. Using broad-spectrum caspase inhibitors and preferential caspase-8 inhibitors, and stabilization of the RyR2 macromolecular complex with a rycal (S107), we showed that early caspase-8 activation increases mitochondrial ROS and NO production, resulting in S-nitrosylation of RyR2 and depletion of calstabin2 from the channel complex causing a diastolic SR Ca 2+ leak that leads to acute pathological left ventricular remodeling.
Results
Effect of TNF-α and Caspase-8 Activation on RyR2 Function in Vitro.
Acute application of TNF-α (1 h, 10 ng/mL) to freshly isolated control cardiomyocytes induced caspase-8 like and caspase-3 like activities sequentially (Fig. S1A ). In addition, application of TNF-α resulted in a progressive and significant increase in the Mitosox Red fluorescence within 1 h in control cells or in myocytes preincubated with a preferential caspase-3/7 inhibitor (Z-DEVD-FMK; 10 μM) (103 ± 10%, n = 30 and 90.5 ± 12%, n = 29, respectively), whereas there was no change in fluorescence in cells preincubated either with preferential caspase-8 inhibitors [Q-LETD-OPh (18), 10 μM; or Z-IETD-FMK, 10 μM] or with broad spectrum caspase inhibitor (Q-VD-OPh; 10 μM) ( Fig. 1 A  and B) . Of note, this mitochondrial ROS production was associated with a significant ΔΨ m depolarization that was inhibited by caspase-8 inhibitors (Fig. S1B) . Several studies have reported that TNF-α increases NO production either acutely through ceramide production and eNOS activation (12) or after induction of iNOS expression (19) . Thus, we tested the effect of TNF-α on NO production by using DAF-FM, which increases its fluorescence when oxidized by NO (20) . TNF-α application caused a progressive increase in the DAF-FM fluorescence, which was inhibited by caspase-8 inhibitor (32 ± 5%, n = 20 vs. 0.2 ± 0.8% n = 20; P < 0.05, Fig. 1 C and D) . TNF-α-induced NO production was also significantly decreased in the presence of a ceramide catabolism inhibitor (NOE; 10 μM), suggesting that caspase-8-induced ceramide production is essential for TNF-induced NO production. Moreover, TNF-α failed to increase NO level when eNOS was inhibited (L-NIO; 1 μM) (Fig.  1D) . These results suggest that TNF-α induced caspase-8 activation is an upstream event in the signaling pathways involving ceramide production (21) and eNOS activation (12) .
Under these proinflammatory conditions, simultaneous production of superoxide anion (O 2 .
− ) and NO can generate peroxynitrite formation (22) . Among proteins involved in excitationcontraction coupling, RyR2 is highly sensitive to peroxynitrite and subsequent S-nitrosylation (13) . In the present study, acute incubation of cardiomyocytes with TNF-α (10 ng/mL) for 1 h was sufficient to cause RyR2 S-nitrosylation and calstabin2 depletion from RyR2 complexes (Fig. 1E) . TNF-α also increases open probability (Po) of RyR2 channels incorporated into planar lipid bilayers (Fig. 1F) and Ca 2+ -spark frequency in intact ventricular cardiomyocytes (Fig. 1G) . In the presence of the caspase-8 inhibitor, Q-LETD-OPh, the TNF-α-induced changes in RyR2
A B E G F D C Mean data ± SEM of normalized MitoSOX red fluorescence after 60 min of TNF-α application. *, statistical difference compared with control conditions (P < 0.05; n ≥ 20 cells in each conditions). Each caspase inhibitor (10 μM) was preincubated 15 min before TNF-α application. For S107 experiments, the animals were orally treated with S107 (25 mg/100 mL, in drinking water) 1 wk before cells isolation. Note that caspase-8 inhibitors (Q-LETD-OPh and Z-IETD-FMK) and broad spectrum caspase inhibitor (Q-VD-OPh) prevents TNF-α-induced mitochondrial ROS production, whereas caspase-3/7 inhibitor (Z-DEVD-FMK) and S107 did not. S-nitrosylation, calstabin2 binding to the RyR2 complex, RyR2 Po, and Ca 2+ sparks frequency were prevented (Fig. 1 E-G) . Of note, RyR2 PKA-dependent phosphorylation site (ser2808) was unchanged (Fig. S2) . The increase in Ca 2+ sparks frequency was also prevented by the RyR Ca 2+ release channel stabilizer "rycal" S107 (Fig. 1G) . Q-LETD-OPh or S107 did not change basal Ca 2+ sparks frequency, and a combined treatment similarly decreased TNF-α-increased sparks frequency compared with a single treatment with Q-LETD-OPh or S107 (Fig. S1C) . However, S107 treatment did not prevent ΔΨ m depolarization (Fig. S1B) , mitochondrial ROS production ( Fig. 1 A and B) , or NO production ( Fig. 1 C and D) , suggesting that RyR2 leak does not affect caspase-8-mediated mitochondrial dysfunction. The antioxidant Nacetyl cysteine (NAC) also normalized Ca 2+ spark frequency (Fig.  1G) . Moreover, TNF-α decreased the Ca 2+ transient amplitude, Ca 2+ release kinetics, SR Ca 2+ load, and cell shortening (Fig. S3 ). Q-LETD-OPh prevented the TNF-α-induced decrease in the Ca 2+ transient amplitude, Ca 2+ release kinetics, SR Ca 2+ load, and cell shortening (Fig. S3) . S107 or NAC did not affect basal Ca 2+ transient characteristics (Fig. S3 B-E) . In such conditions and in agreement with a previous report (2), TNF-α induced positive effects on Ca 2+ handling and cell shortening (Fig. S3 B-E) . Thus, TNF-α-mediated ROS/NO production via caspase-8 activation increased RyR2 S-nitrosylation and SR Ca 2+ leak.
Roles of Caspase-8 and RyR2 Leak in Myocardial Reperfusion Injury.
To determine whether the TNF-α-induced SR Ca 2+ leak via RyR2 channels contributes to reperfusion injury, we performed 30 min of ischemia followed by reperfusion in vivo in rats. TNF-α plasma levels were detected at 1 h and returned to baseline 6 h after reperfusion (276 ± 48 pg/mL at 1 h, n = 6; Fig. 2A ). In parallel, cardiac caspase-8 activity was also significantly increased by 1 h after reperfusion, peaked at 6 h, and returned to baseline by 24 h (Fig. 2B ). In addition, Bid cleavage increased significantly after 24 h of reperfusion as shown by the increase level of the truncated Bid isoform (Fig. S4 ). RyR2 S-nitrosylation and calstabin2 depletion were also observed 24 h after reperfusion (Fig.  2C ) without any change in phosphorylation of RyR2 at ser2808 (Fig. S2 ). S107 (25 mg/100 mL, in drinking water) treatment for 1 wk before surgery prevented calstabin2 depletion from the RyR2 complex but did not affect S-nitrosylation of the channel (Fig. 2C ). In contrast, Q-LETD-OPh treatment (1 mg/kg i.p.) 15 min before reperfusion inhibited both RyR2 S-nitrosylation and depletion of calstabin2 from the RyR2 complex (Fig. 2C ). In addition, both S107 and Q-LETD-OPh significantly reduced myocardial infarct size [infarct area/area at risk (IA/AAR)] compared with DMSO-treated rats (Fig. 2D ). Similar experiments were performed with an anti-TNF-α (Etanercept) treatment before surgery. As with S107 or Q-LETD-OPh, Etanercept reduced infarct size by ≈50% (Fig. S5 ). The severity of the ischemic insult was similar in the different groups, as shown by the ratios of AAR relative to ventricle area (V) (AAR/V= 39 ± 8% in DMSO treated, n = 10; 35 ± 6% in Q-LETD-OPh treated, n = 8; 38 ± 6% in S107 treated, n = 5; 39 ± 7% in Etanercept treated). Moreover, on calstabin2 KO mice, myocardial infarct size was significantly increased compared with WT mice and S107 was inefficient, whereas it reduced significantly infarct size in WT (Fig. S6A) . Similarly, RyR2 S-nitrosylation was increased in calstabin2 KO after I/R (Fig. S6B ). Altogether these results corroborate in vivo the role of TNF-α in caspase-8/RyR2-mediated reperfusion injury.
SR Ca 2+ leak is thought to play a role in triggering arrhythmias during the early phase of reperfusion (23, 24) . We observed numerous ventricular extrasystoles and sustained ventricular tachycardia during the first 12 h of reperfusion ( Fig. S7 A-E). Q-LETDOPh and S107 treatment both significantly reduced arrhythmias ( Fig. S7A and C-E). In WT mice injected with TNF-α, we measured Bid cleavage, RyR2 S-nitrosylation, calstabin2 dissociation, and ventricular arrhythmias (Figs. S7F and S8). As for I/R, TNF-α in vivo significantly increased ventricular extrasystoles, Bid cleavage, RyR2 S-nitrosylation, and calstabin2 dissociation. All these effects were prevented by caspase-8 inhibition (Figs. S7F and S8). Thus, inhibition of caspase-8 and prevention of calstabin2 depletion from the RyR2 complex with S107 prevents early reperfusion injury and associated arrhythmias.
Role of Caspase-8 and RyR2 Leak in Left Ventricular Remodeling. We subsequently analyzed and compared the longer-term effects of either early caspase-8 inhibition or S107 treatment on left ventricular remodeling 15 d after myocardial reperfusion. Histological analyses of the left ventricle were performed by using Masson trichrome staining to detect collagen fibers. There was an increase in extracellular matrix (i.e., fibrosis) that was prevented when animals were treated with Q-LETD-OPh (1 mg/kg i.p.), 15 min before the reperfusion or pretreated with S107 (25 mg/100 mL in the drinking water) 1 wk before ischemia and up to 72 h after reperfusion, compared with vehicle-treated animals ( nificantly increased in DMSO-treated animals and unchanged in Q-LETD-OPh or S107-treated animals ( Fig. 3B ). After I/R, the rats exhibited evidence of cardiac dysfunction with an increase in LVtd and a decrease in fractional shortening (Fig. 3C) , both of which were significantly improved in animals treated with Q-LETD-OPh or S107 (Fig. 3C) .
The cardiac ventricular remodeling observed 2 wk after reperfusion was associated with RyR2 S-nitrosylation, calstabin2 depletion from the RyR2 complex, without any modification of RyR2 phosphorylation at ser2808 (Fig. 4A and Fig. S2) , and with an increase in RyR2 channel Po measured under conditions corresponding to diastole (low activating [Ca 2+ ] ≈150 nM; Fig.  4B ). These results are consistent with a diastolic SR Ca 2+ leak. Once again, S107 inhibited depletion of calstabin2 from the RyR2 complexes without affecting S-nitrosylation of RyR2, whereas Q-LETD-OPh normalized both. RyR2 channel PO, measured at 150 nM cytosolic Ca 2+ , was partially or totally reduced to that observed in control channels from animals treated with S107 or Q-LETD-OPh, respectively. At the cellular level, Ca 2+ transient amplitudes were decreased by ≈20% and the rising phases was significantly slower in vehicle-treated animals ( Fig. S9 A and B) . These changes were accompanied by decreased SR Ca 2+ content and fractional cell shortening (Fig. S9 C and D) . Thus, S107 or Q-LETD-OPh treatment prevented altered Ca 2+ handling and impaired cell shortening.
Cytosolic Ca 2+ regulates the nuclear translocation of some transcription factors and the expression of Ca 2+ -dependent genes known to contribute to ventricular remodeling (25) . In that context, we hypothesized that the diastolic SR Ca 2+ leak via RyR2 channels after I/R might contribute to the cardiac remodeling process. The nuclear factor of activated T cells (NFAT) is a transcription factor involved in cardiac hypertrophy (26) . Elevated cytosolic [Ca 2+ ] i activates the calmodulin-activated serine/ threonine protein phosphatase calcineurin, which dephosphorylates NFATc resulting in nuclear translocation of NFAT and activation of hypertrophy genes (27) and immunologically important genes, such as TNF-α (28). We examined cytosolic to nuclear translocation of NFAT and observed increased NFAT after I/R (Fig. 4C) . When the animals were treated with caspase-8 inhibitor (Q-LETD-OPh) or rycal (S107), NFAT was retained in the cytosol at levels similar to those observed in sham-operated animals and may contribute to the reduction in hypertrophy shown in Fig. 3B . Additionally, mRNA levels of the heart failure marker ANF were also significantly reduced with both treatments (Fig. 4D) . In addition to lower levels of collagen (Fig. 3A) , interstitial fibrosis as evidenced by increased levels of fibronectin mRNA was also prevented by caspase-8 inhibition or S107 inhibition of SR Ca 2+ leak (Fig. 4D) . I/R also increased mRNA levels of molecules involved in TNF-α signaling including TNFR1, TNFR2, caspase-8, and TNF-α (Fig. 4E ). This increase in mRNA levels was prevented by the caspase-8 inhibitor (Q-LETD-OPh) and by S107, suggesting a reduced inflammatory response. Taken together, these results indicate that an increase in ROS and NO production, via early caspase-8 activation, induces RyR2 S-nitrosylation and diastolic SR Ca 2+ leak, which contribute to I/R injury and long-term left ventricular remodeling.
Discussion
The therapeutic strategy of rapid reperfusion of ischemic myocardium is designed to preserve cardiac function. However, reperfusion itself has notable adverse effects including arrhythmias and cell death (29, 30) . We now show that inhibiting RyR2 mediated diastolic SR Ca 2+ leak with a unique orally available drug called rycal (S107), which stabilizes the channel, or by caspase-8 inhibition, significantly reduces reperfusion injury, infarct extension, and left ventricular remodeling in the later phase of reperfusion (i.e., 15 d after reperfusion). LV remodeling after ischemia is caused by multiple factors including: (i) myocardial cell death; (ii) ROS production and inflammatory cytokines; (iii) structural changes of myocardium in response to mechanical stress; and (iv) myocardial fibrosis (31, 32) . The present study reports the unique finding that inhibition of RyR2 mediated diastolic SR Ca 2+ leak before the reperfusion is sufficient to substantially reduce reperfusion injury, myocardial cell death, fibrosis, left ventricular remodeling, and inflammation.
In this study, we present a unique TNF-α-mediated signaling pathway wherein caspase-8 activation leads to S-nitrosylation of RyR2 and calstabin2 depletion from the channel complex. The subsequent increase in diastolic SR Ca 2+ leak contributes to reperfusion injury and left ventricular remodeling after acute I/R. TNFR1 is a death receptor that activates initiator caspases including caspase-8 (8) . The resulting activation of caspase-8 is either sufficient to trigger the proteolytic activation of other caspases (i.e., caspase-3), or requires the proteolytic activation of proapoptotic proteins of the Bcl2 family in particular Bid, which triggers a loss of mitochondrial inner membrane potential Δψm and ROS generation (10, (33) (34) (35) . In cardiomyocytes, caspase-8 inhibition prevented TNF-α-induced loss of Δψm and mitochondrial release of cytochorme c (10). Alternatively, the TNF/TNFR1 complex is thought to regulate sphingolipid signaling pathways (36) . After TNF-α binds to TNFR1 an early weak recruitment of FADD and stimulation of caspase-8 in the cell are sufficient to activate sphingomyelinase (21) . Activation of sphingomyelinase initiates sphingolipid metabolism with ceramide, sphingosine, and sphingosine-1-phosphate formation and permits death-receptor oligomerization and caspase-8 activation (37) . These bioactive phospholipids induce cellular responses, such as mitochondrial ROS production (38) and NO synthesis (39) . Hence, early inhibition of caspase-8 prevents TNF-α induced mitochondrial dysfunction and NO production (10) (Fig. 1) . Concomitant ROS production and NO production would affect cellular signaling most likely through peroxynitrite formation and S-nitrosylation (13, 22) . Oxidation of thiols on RyR2 may activate the channels resulting in a diastolic SR Ca 2+ leak under pathological conditions (13, 15) . Here, we show that S-nitrosylation and diastolic SR Ca 2+ leak are associated with calstabin2 depletion from the channel complex, which is prevented by pharmacological inhibition of caspase-8 or with rycal S107 treatment. Of note, only caspase-8 inhibition prevented both calstabin2 depletion and S-nitrosylation. These results suggest that changes in the redox environment of the channel may lead to calstabin2 depletion and increased RyR2 channel activity under pathological conditions as shown in heart failure (15, 17) .
SR Ca 2+ leak is thought to trigger cellular damage after acute ischemia and reperfusion. Several studies have reported RyR2 dysfunction after I/R (24). Ca 2+ overload has been reported to play a pathological role after reperfusion and ventricular arrhythmias (40, 41) . Moreover, reperfusion is associated with the recovery of ATP phosphorylation potential, which restores SR Ca 2+ -ATPase activity and increases Ca 2+ sequestration into the SR (24) . SR Ca 2+ overload can cause oscillations of cytosolic Ca 2+ .
Short-term oscillations in cytosolic Ca
2+ have been implicated in the genesis of reperfusion arrhythmias (23) . Indeed, caspase-8 inhibition, which prevents early RyR2 dysfunction, has a profound impact on reperfusion arrhythmias (Fig. 2) . In addition, these results suggest a connection between circulating TNF-α levels and arrhythmias in acute ischemia (42, 43) .
During I/R, aberrant intracellular Ca 2+ leak is taken up by the mitochondria (44) . Ca 2+ accumulation in the mitochondria leads to activation of mitochondrial permeability transition pore (MPTP) (45) . Immediately after MPTP activation, mitochondria swell and release apoptogenic factors like cytochrome c and AIF, which activates caspase-dependent and independent execution of apoptosis. This study points out a potential involvement of a dual detection mechanisms sensitizing large-scale MPTP opening and mitochondrial membrane permeabilization (46) (47) (48) . Accordingly, this sensitizing mechanism suggests that caspase-8-induced mitochondrial depolarization alone, without SR Ca 2+ leak, will not be sufficient to trigger cell death but would require a commitment [Ca 2+ ] mito oscillations. Discrete modification of the SR Ca 2+ leak may thus be sufficient to prevent large scale swelling and allowing functional recovery of the mitochondria (46) (47) (48) . The present study suggests that leaky RyR2 may contribute to mitochondrial Ca 2+ accumulation during I/R and to an amplification loop leading to reperfusion injury (9) given that inhibiting calstabin2 dissociation from the RyR2 complex reduces RyR2-mediated SR Ca 2+ leak and is protective. Improving SR Ca 2+ handling thus appears to be a potential unique target for reducing reperfusion injury, independently of reducing arrhythmia occurrence per se (24, 49) .
In conclusion, the present study highlights the pathophysiological roles of TNF-α-induced caspase-8 activation and ROS/ NO production, in the control of RyR2 function after acute myocardial infarction. Early reperfusion induced S-nitrosylation of RyR2 and calstabin2 depletion from the channel complex. Caspase-8 activation also participates in reperfusion injury. Thus, both caspase-8 inhibition and RyR2/calstabin2 normalization are potential targets for the prevention of the effects of reperfusion, including myocardial cell death, arrhythmias, and late left ventricular remodeling after acute myocardial infarction.
Materials and Methods
See SI Materials and Methods for detailed descriptions.
Animal Model and Cell Dissociation. Eight-week-old Wistar Kyoto rats (Janvier) were used. The investigations conformed to the guidelines for the Care and Use of Laboratory Animals (National Institutes of Health No. 85-23, revised 1996) and European directives (96/609/EEC). For I/R protocol, the left coronary artery was ligated for 30 min (rats) and 1 h (mice). After 15 min of ligation, animals were randomly given vehicle (10% DMSO in 0.9% saline), Q-VD-OPh (i.p., 1 mg/kg in 10% DMSO), or Q-LETD-OPh (i.p., 1 mg/kg in 10% DMSO). In some experiments, animals were pretreated with S107 (25 mg/100 mL in the drinking water) 1 wk before ischemia and up to 72 h after reperfusion). Single cardiomyocytes were enzymatically isolated from the left ventricles as described before (50) .
Statistics. Data are presented as mean ± SEM. Statistical significance was assessed by using the Student t test (for paired or unpaired samples) or when three or more groups were compared, one-way analysis of variance (ANOVA) with a Newman-Keuls post hoc test. P < 0.05 was considered significant. (1, 2) . In contrast to Z-and -FMK based inhibitors, the broad-spectrum caspase inhibitor Quinoline-carbonyl-Val-Asp-Difluorophenoxymethylketone (Q-VD-OPh; MP Biomedicals #:OPH109) has low toxicity, broad spectrum effects on caspases, and no inhibitory effect on noncaspase enzymes (3) . N α -Quinoline-2-carbonyl-LETD(OMe)-CH 2 OC 6 H 3 (2,6-F 2 ) referred here as Q-LETD-OPh was custom-synthesized (95% purity, NeoMPs). Q-LETD-OPh is a preferential caspase-8 inhibitor reported under the name TRP801 (4), All inhibitors were dissolved at 10 −2 M in DMSO and stored at −20°C. Etanercept (Enbrel; Pfizer) was i.p. injected (2 mg·kg After 15 min of ligation, animals were randomly given vehicle (10% DMSO in 0.9% saline), Q-VD-OPh (i.p., 1 mg/kg in 10% DMSO), or Q-LETD-OPh (i.p., 1 mg/kg in 10% DMSO). After 30 min of occlusion, the ligation was removed and the left coronary artery was reperfused. The chest cavity was compressed to remove any air before being hermetically sealed. Rats were randomly assigned to study groups according to the duration of left coronary reperfusion: from 1 h (day 0-1 h) to 15 d and the caspase inhibitor treatment. Sham-operated animals were subjected to the same surgical procedure, but the ligation remained untied. In some experiments rats were pretreated with S107 (25 mg/100 mL in the drinking water) 1 wk before ischemia and up to 72 h after reperfusion). Similar procedure was used for WT and calstabin2 KO mice except for the duration of acute ischemia (1 h).
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Animals were killed by rapid neck disarticulation, and the heart was excised. Single cardiomyocytes were enzymatically isolated from the left ventricles as described (5) . After being loaded with fluorescent indicators (see below), cardiomyocytes were plated on laminin-coated coverslips that made up the bottom of the perfusion chamber. Cells were superfused with standard Tyrode solution: 117 mM NaCl, 5.7 mM KCl, 4.4 mM NaHCO 3 , 1.5 mM KH 2 PO 4 , 1.7 mM MgCl 2 , 21 mM Hepes, 11 mM glucose at pH 7.4 adjusted with NaOH. Experiments were performed at room temperature (≈24°C). Cells were continuously stimulated at 1 Hz with 1-to 2-ms current pulses delivered via two platinum electrodes, one on each side of the perfusion chamber.
Histology. Thin sections (5 μm) were prepared from the rat left ventricles and stained with Haematoxylin-Eosin (HE) and Masson trichrome (MT) for light microscopy (10×). The thickening of the myocardium was estimated on the HE-stained heart sections, and the presence of collagen was analyzed on the MTstained ventricle sections. Results indicate the percent of fibrosis area expressed as a percentage of collagen content area of myocardial tissue analyzed.
Echocardiography. Cardiac function was assessed by using echocardiography (Vivid 7; General Electric Healthcare) with a linear 14 MHz probe, 15 d after reperfusion. A 2D view of the left ventricular (LV) was obtained at the level of the papillary muscles in a parasternal short-axis view. M-mode traces were recorded through the anterior and posterior walls. Morpho-functionnal parameters were assessed by using left ventricular end diastolic diameter (LVEDd), fractionnal shortening (FS), and E wave over A wave ratio (E/A) parameters.
Recording and Analysis of ECG. Rats and mice were monitored with ECG recordings by using a signal transmitter-receiver (RPC-1; DSI) connected to a data acquisition system (IOX2; EMKA Technologies). The data were collected continuously over 24 h at a sampling rate of 1,000 Hz. Continuous digital recordings were analyzed offline by using the software ECG-auto (ver 1.5.12.22, EMKA Technologies). ECG signals were digitally filtered between 0.1 and 1,000 Hz and analyzed manually to detect arrhythmias over 2 h of reperfusion in animal treated with the vehicle (DMSO, i.p. injected), S107 (drinking water; 25 mg/100 mL), or Q-LETD-OPh (i.p. injected). The mean RR interval (milliseconds) and the SD of all normal RR intervals (SDNN, reflecting total autonomic variability) were calculated. ] was evaluated by using the fluorescent Ca 2+ indicator Fluo-4 and confocal microscopy in the line-scan mode using a Zeiss LSM 510 inverted confocal microscope (Zeiss) equipped with a 63× lens (H 2 O immersion, numerical aperture, N.A. = 1.2). To enable comparisons between cells, changes in the Fluo-4 fluorescence signal (ΔF) were divided by the fluorescence immediately before a stimulation pulse given under control conditions (F 0 ). The rising phase of Ca 2+ transients was assessed by normalizing the peak amplitude over the time to peak (Amp/TT). Ca 2+ sparks were analyzed as reported (6) . Confocal images were obtained by line scanning along the long axis. Line-scan rate was set to 1.54 ms per line; 512 pixels × 3,000 lines. Ca 2+ -spark frequency was calculated for each cardiomyocyte as the number of sparks recorded on 10 successive images collected at 3-4 different line locations. The SR Ca 2+ content was measured in intact cardiomyocytes loaded with Fluo-4. After 5 min of electrical field stimulation at 1 Hz, rapid perfusion of caffeine (20 mM) was used to release the SR Ca 2+ store. Cell shortening was measured from the line-scan images and expressed as a percentage of the resting cell length.
Nitric Oxide and Mitochondrial ROS Production. DAF-FM was used to measure cytosolic NO level (7) . Isolated cardiomyocytes were loaded with DAF-FM (2 μM) in Tyrode solution for 15 min at room temperature. Confocal images were obtained at 5-min intervals by measuring the emitted light at 515 nm after an excitation at 488 nm.
MitoSOX Red was used to measure mitochondrial ROS production (8) . Isolated cardiomyocytes were loaded with Mi-toSOX Red (5 μM) in Tyrode for 30 min at 37°C, followed by washout. Confocal images were obtained at 5-min intervals by measuring the emitted light at 585 nm after excitation at 488 nm. MitoSOX Red fluorescence was measured in five different areas in each cell, and the signal was normalized to that at the start of the experiment. As a positive control, 1 mM H 2 O 2 was added at the end of each experiment, and this resulted in a marked increase in the fluorescence signal in all cells.
Mitochondrial Membrane Potential. TMRM was used to measure mitochondrial membrane potential (ΔΨ m ) (8) . Isolated cardiomyocytes were loaded with TMRM (10 nM) in Tyrode solution for 20 min at room temperature, followed by washout in medium without TMRM. Confocal images of TMRM fluorescence were obtained by measuring the emitted light at 585 nm after excitation at 568 nm. To minimize the impact of subcellular variability in ΔΨ m , TMRM fluorescence was measured in five different areas in each cell (8) . Images were taken every 5 min and fluorescence signals were normalized to the fluorescence measured at the start of the experiment. At the end of each experiment, cells were exposed to the mitochondrial uncoupler FCCP (1 μM) to determine the dynamic range of the dye.
Sarcoplasmic Reticulum Vesicle Preparation. Approximately 200 mg of isolated rat left ventricular tissue was homogenized by using a tissue mixer (Fisher Scientific) at the highest speed for 1 min with 2 volumes of: 20 mM Tris-maleate at pH 7.4, 1 mM EDTA, and protease inhibitors (Roche). Homogenate was centrifuged at 4,000 × g for 15 min at 4°C and the following supernatant was centrifuged at 40,000 × g for 30 min at 4°C. The final pellet, containing the SR fractions, was resuspended and aliquoted by using the following solution: 250 mM sucrose, 10 mM Mops at pH 7.4, 1 mM EDTA, and protease inhibitors. Samples were frozen in liquid nitrogen and stored at −80°C.
Immunoprecipitation and Immunoblots Analysis. Cardiac SR microsomes (100 μg) were isotonically lysed in 1.0 mL of a buffer containing 50 mM Tris·HCl at pH 7.4, 150 mM NaCl, 20 mM NaF, 1.0 mM Na 3 VO 4 , and protease inhibitors. An anti-RyR antibody (4 μg of 5029 Ab) was used to immunoprecipitate RyR2 from 100 μg of cardiac SR microsomes. The samples were incubated with antibody in 0.5 mL of a modified RIPA buffer (50 mM Tris·HCl at pH 7.4, 0.9% NaCl, 5.0 mM NaF, 1.0 mM Na 3 VO 4 , 1% Triton-X100, and protease inhibitors) for 1 h at 4°C. The immune complexes were incubated with protein A Sepharose beads (Sigma) at 4°C for 1 h, and the beads were washed three times with buffer. Proteins were separated on SDS/PAGE gels (6% for RyR2, 15% for calstabin) and transferred onto nitrocellulose membranes for 1 h at 200 mA (SemiDry transfer blot; BioRad). RyR2 S-nitrosylation was measured by developing immunoblots with both a RyR antibody (Affinity Bioreagents) and an anti-Cys-NO antibody (Sigma), whereas RyR2 PKA phosphorylation at S2808 was measured by developing immunoblots with an anti-pS2808 antibody (9) . The amount of calstabin2 that coimmunoprecipitated with RyR2 was determined from immunoblots developed with a calstabin antibody (Santa Cruz Biotechnology). Levels of RyR2-bound proteins were normalized to the total RyR2 immunoprecipitated (arbitrary units). All immunoblots were developed and quantified by using the Odyssey Infrared Imaging System (LICOR Biosystems) and infrared-labeled secondary antibodies.
Single-Channel Data Acquisition and Analysis. SR vesicles containing RyR2 were fused to planar lipid bilayers formed by painting a lipid mixture of phosphatidylethanolamine and phosphatidylcholine (Avanti Polar Lipids) in a 3:1 ratio across a 200-μm hole in polysulfonate cups (Warner Instruments) separating two chambers. The final concentration of lipids was 40 mg/mL dissolved in decane. Membrane thinning was assayed by applying a triangular wave test pulse. Typical capacitance values were 100-250 pF. The trans chamber (1.0 mL), representing the intra-SR (luminal) compartment, was connected to the head stage input of a bilayer voltage clamp amplifier. The cis chamber (1.0 mL), representing the cytoplasmic compartment, was held at virtual ground. in the cis chamber was calculated with WinMaxC program (version 2.50; www.stanford.edu/∼cpatton/maxc.html). SR vesicles were added to the cis side and fusion with the lipid bilayer was induced by making the cis side hyperosmotic by the addition of 400-500 mM CsCl. After the appearance of chloride channels, the cis side was perfused with the cis solution. Single-channel currents were recorded at 0 mV by using a Bilayer Clamp BC-525D amplifier (Warner Instruments) and filtered with a low-pass Bessel filter eight pole (Warner Instruments) at 1 kHz and then sampled at 4 kHz. Data acquisition was performed by using Digidata 1322A and Axoscope 10 software (Axon Instruments). At the conclusion of each experiment, 5 μM ryanodine or 20 μM ruthenium red was applied to confirm RyR2 channel identity. The recordings were analyzed by using Clampfit 10.1 (Molecular Devices) and Sigma Plot software (ver. 8.0, Systat Software).
Caspase Activation. The animals were killed by a pentobarbital lethal injection. The heart was excised and perfused for ≈5 min by Langerdorf reverse way by using a calcium-free washing solution (117 mM NaCl, 5.7 mM KCl, 4.4 mM NaHCO 3 , 1.5 mM KH 2 PO 4 , 1.7 mM MgCl 2 , 21 mM Hepes, 11 mM glucose, 20 mM taurine at pH 7.2 adjusted with NaOH). The left ventricle was then dissected. Next, 2 mm 3 was mechanical crushed in ice in the extraction buffer [10 mM Hepes at pH 7.4, 42 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.5% CHAPS, 0.1 mM EDTA supplemented with protease inhibitors (1 mMPMSF, 1 μg/mL leupeptin, 1μg/mL pepstatin A, 1 μM cytochalasin B, 10 μg/mL chymopapain, and 1μg/mL antipain)].
After centrifugation (10 min, 4°C, 2,000 × g), 100 μg of supernatant was 1/10 diluted in a caspase activity buffer (50 mM Hepes at pH 7.4, 100 mM NaCl, 10 mM DTT, 0.1% CHAPS, 1 mM EDTA) to a final volume of 90 μL. The plate was incubated at 37°C during 3 h in the dark with Ac-IETD-AMC. The measure was carried out by spectrofluorimetry (λex = 380 nm; λem = 460 nm).
Caspase activity was also assessed on isolated cardiomyocytes by measuring the activation of caspase-8 or caspase-3/7 by confocal imaging by using a fluorescent caspase inhibitor (FLICA; ImmunoChemistry Technologies LLC). The carboxyfluorescein (FAM)-labeled caspase inhibitors FAM-IETD-FMK and FAM-DEVD-FMK were obtained from Abcys. Isolated cardiomyocytes were loaded by following the commercial procedure, and fluorescence was detected with excitation and emission wavelength at 488 nm and 515 nm, respectively.
TNF-α Levels. Blood samples were withdrawn from the descending aorta at different time after reperfusion and allowed to clot 20 min at room temperature. Samples were then centrifugated at 2,000 × g during 10 min at 4°C. Sera were aliquoted, quick frozen, and stored at −20°C. TNF-α levels were determined by using xMAP luminex technology with a Bio-Rad multiplex cytokine assay kit by following the commercial procedure.
RNA Extraction and Real-Time RT-QPCR. Total RNA was extracted from ≈15 to 25 mg of left ventricular cardiac tissue, using TRIzol reagent according to the manufacturer's protocol (Euromedex), then treated with DNase I (Invitrogen) at 37°C for 30 min. cDNA was synthesized by using SuperScript II reverse transcriptase (Invitrogen) at 42°C for 50 min. RT-QPCR was performed in duplicates by using a LightCycler rapid thermal cycler (Roche). Twenty-microliter reaction mixture contained 10 μL of ABsolute QPCR SYBR Green Capillary Mix (Thermo Fisher Scientific; containing thermo start DNA polymerase, reaction buffer, deoxynucleoside trisphosphate mix, 3 mM MgCl 2 and SYBR Green I dye), was added with 0.5 μM of appropriate primer mix, and 5 μL of cDNA. Forward and reverse primers for each gene were chosen on the basis of previously published sequences (ANF: forward primer ATACAGTGCGGTGTCCAACA/reverse primer CGA-GAGCACCTCCATCTCTC; fibronectin: forward primer CCA-GGCACTGACTACAAGAT/reverse primer CATGATACCA-GCAAGGAGT; TNFR1: forward primer GGGATTCAGCTC-CTGTCAAA/reverse primer ATGAACTCCTTCCAGCTGGT; TNFR2: forward primer ATGGTGCCTCATCTGCC/reverse primer GGACCTGCTCATCCTTTG; caspase-8: forward primer CTGGGAAGGATCGACGATTA/reverse primer TGGTCAC-CTCATCCAAAACA; TNF-α: forward primer GTCGTAGCA-AACCACCAAGC/reverse primer TGTGGGTGAGGAGCAC-ATAG). The data were normalized to the levels of GAPDH. The amplification program included the initial denaturation step at 95°C for 15 min, and 40 cycles of denaturation at 95°C for 1 s, annealing at 65°C for 10 s, and extension at 72°C for 20 s. Melting curves were used to determine the specificity of PCR products.
NFAT Quantification. Proteins from five rats treated with DMSO, six rats treated with S107, and four rats treated with Q-LETD-OPh were extracted. The total protein concentration was determined with the Bio-Rad assay (Bio-Rad). Equal amounts (50 μg) of cytosolic/nuclear protein were separated by 10% SDS/PAGE followed by immunoblotting with a Trans-Blot Semi-Dry (BioRad), following the manufacturer's protocol. The antibodies used were as follows: rabbit GAPDH antibodies were from Abcam (1:2,500) and rabbit NFAT4 antibody was from Santa Cruz Biotechnology (1:400). Western blots were revealed with the ECLplus reagent (GE Healthcare) and scanned with an Ettan-DIGE Imager (GE Healthcare). Densitometric analysis was performed with NIH Image/ImageJ, and the expression level of each protein was normalized to GAPDH for cytoplasmic signals. 
